### What Is Ozempic, or Semaglutide? Ozempic is a medication used to manage blood sugar levels in people with type 2 diabetes. It also helps with weight loss and is sold under the name Wegovy for treating obesity. Wegovy is available in higher doses compared to Ozempic. ### Why Is There a Shortage? The shortage of Ozempic and Wegovy is mainly due to increased demand driven by social media trends and reports of celebrities using the drug for weight loss. This has led to people without diabetes or obesity seeking the drug, often paying out of pocket. ### Impact on People with Diabetes and Obesity The shortage affects both people with diabetes and those with obesity who rely on these medications for treatment. However, there are alternative medications available, such as liraglutide (Victoza), dulaglutide (Trulicity), and exenatide (Bydureon), which belong to the same class of drugs as semaglutide. ### Research on Weight Loss Benefits Clinical trials have shown that semaglutide can lead to significant weight loss. In one study, participants lost an average of 15% of their body weight, which is comparable to results from weight-loss surgery. ### Side Effects While effective, semaglutide is not without risks. Common side effects include gastrointestinal issues like nausea, diarrhea, and constipation. Serious side effects can include pancreatitis, gallstones, and kidney injury. ### Cost and Insurance The cost of semaglutide varies. Ozempic is generally cheaper and more likely to be covered by insurance compared to Wegovy. However, both drugs can be expensive without insurance coverage. ### Conclusion People with diabetes and obesity have alternative treatment options if they cannot access Ozempic or Wegovy. It's essential to consult healthcare providers for the best course of action during this shortage.